Guardian Pharmacy Q3 revenue $314M (+20% YoY); Adj. EBITDA $23M (+20%); guides FY24

Guardian Pharmacy Services, Inc.

Revenue of $314.4M (+20% YoY) driven by organic growth and Heartland Pharmacy acquisition.
Net loss of $105.8M due to $122.4M share-based comp from IPO; Adj. EBITDA of $23.0M (+20% YoY).
Resident count of 180,000 at quarter-end, up 12% YoY.
FY 2024 guidance: revenue $1.205B-$1.215B, Adjusted EBITDA $86.5M-$87.0M.
Completed a small acquisition in Q3, entering a new market with a strong operating team.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.